Colony Group’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-39
Closed -$1K 295
2015
Q4
$1K Hold
39
﹤0.01% 723
2015
Q3
$1K Hold
39
﹤0.01% 790
2015
Q2
$1K Sell
39
-206
-84% -$3.98K ﹤0.01% 696
2015
Q1
$5K Hold
245
﹤0.01% 626
2014
Q4
$5K Hold
245
﹤0.01% 644
2014
Q3
$5K Hold
245
﹤0.01% 696
2014
Q2
$5K Hold
245
﹤0.01% 610
2014
Q1
$5K Hold
245
﹤0.01% 650
2013
Q4
$5K Buy
+245
New +$4.77K ﹤0.01% 573

Other funds holding BTAL

Colony Group's BTAL Position: Q1 2016 in Review

Colony Group sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q1 2016, closing a stake of 39 shares — an estimated $1K sold.

Colony Group first reported a position in BTAL in Q4 2013 and held it in 9 quarters. The position peaked at $5K in Q1 2015. 8 funds tracked by Wall St. Rank hold BTAL as of Q1 2016.

  • Colony Group reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q1 2016 after selling out during the quarter.
  • Colony Group sold 39 AGF US Market Neutral Anti-Beta Fund shares in Q1 2016, an estimated $1K.
  • Colony Group first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2013 and held it in 9 quarters.
  • Colony Group's AGF US Market Neutral Anti-Beta Fund position peaked at $5K in Q1 2015.
  • 8 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q1 2016.

Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.